Showing posts with label Anaphylaxis. Show all posts
Showing posts with label Anaphylaxis. Show all posts

Wednesday, September 25, 2013

0 The acute and long-term management of anaphylaxis: protocol for a systematic review

Open AccessStudy protocol

The acute and long-term management of anaphylaxis: protocol for a systematic review



Sangeeta Dhami, Sukhmeet S Panesar, Tamara Rader, Antonella Muraro, Graham Roberts, Margitta Worm and Aziz Sheikh










For all author emails, please log on.








Clinical and Translational Allergy 2013, 3:14 doi:10.1186/2045-7022-3-14

Published: 10 April 2013







Abstract (provisional)


Background


The European Academy of Allergy and Clinical Immunology is in the process of developing its Guideline for Food Allergy and Anaphylaxis, and this systematic review is one of seven inter-linked evidence syntheses that are being undertaken in order to provide a state-of-the-art synopsis of the current evidence base in relation to epidemiology, prevention, diagnosis and clinical management and impact on quality of life, which will be used to inform clinical recommendations.

The aims of this systematic review will be to assess the effectiveness of interventions for the acute management of anaphylaxis, and pharmacological and non-pharmacological approaches for the long-term management of anaphylaxis.

Methods


A highly sensitive search strategy has been developed, and validated study design filters will be applied to retrieve all articles pertaining to the management of anaphylaxis from electronic bibliographic databases. We will systematically review the literature on the acute management of anaphylaxis by assessing the effectiveness of epinephrine, H1-antihistamines (versus placebo), systemic glucocorticosteroids, methylxanthines or any other treatments for the emergency management of people experiencing anaphylaxis. The main interventions that have been studied in the context of long-term management are anaphylaxis management plans and allergen-specific immunotherapy.

Discussion


There is at present little in the way of robust evidence to guide decisions on the acute and/or long-term management of anaphylaxis. Given the risk of death and the considerable morbidity associated with anaphylaxis these evidence gaps need to be filled wherever possible; this systematic review will make a start in this area.




The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.






0 Clinical evaluation of pediatric anaphylaxis and the necessity for multiple doses of epinephrine














Full Text

Original Article  Open Access


















     |   

















Asia Pac Allergy. 2013 Apr;3(2):106-114. English.
Published online 2013 April 26.  http://dx.doi.org/10.5415/apallergy.2013.3.2.106 
Copyright © 2013. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.




































Clinical evaluation of pediatric anaphylaxis and the necessity for multiple doses of epinephrine

Naoyuki Inoue, and Asuka Yamamoto
Department of Pediatrics, Inagi Municipal Hospital, 1171 Omaru, Inagi, Tokyo 206-2801, Japan.

 Correspondence: Naoyuki Inoue. Department of Pediatrics, Inagi Municipal Hospital, 1171 Omaru, Inagi, Tokyo 206-2801, Japan. Tel: +81-42-377-0931, Fax: +81-42-377-1156, Email: nao2014272@yahoo.co.jp 

Received January 08, 2013; Accepted March 25, 2013.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background
Epinephrine administered intramuscularly is the treatment of choice for anaphylaxis, and more than 1 dose is occasionally required.


Objective
To determine clinical background of anaphylaxis for improving the treatment, management, and prognosis of anaphylaxis.


Methods
Children who had satisfied the diagnostic criteria for anaphylaxis according to the National Institute of Allergy and Infectious Disease Food Allergy and Anaphylaxis Network were selected from our hospital from April 1, 2009 to March 31, 2012.


Results
We analyzed 61 patients from the ages of 2 months to 14 years who satisfied the diagnostic criteria for anaphylaxis. Parents of 32 children (52.5%) reported that they had been administered single dose of epinephrine, and 3 children (4.9%) reported receiving multiple doses of epinephrine. The latter group experienced syncope more often (p = 0.049) than the former and suffered more often from comorbid allergic diseases (p = 0.043) that included either bronchial asthma, allergic rhinitis, or atopic dermatitis. Two (3.3%) children experienced biphasic reactions. Patients who experienced a biphasic reaction were more likely to have experienced syncope (p = 0.033), vomiting (p = 0.02), and administration of multiple doses of epinephrine (p = 0.0016).


Conclusion
Our findings lead us to recommend that children receiving more than 1 injection of epinephrine should be observed for 24 hours, because it seems that children with requiring more than 1 injection of epinephrine might be have biphasic reactions.
















Keywords: Epinephrine, Children, Biphasic anaphylaxis, Anaphylaxis.










Thursday, September 19, 2013

0 Acute treatment of anaphylaxis in children


Logo of canfamphys









Can Fam Physician. 2013 July; 59(7): 740-741.





PMCID: PMC3710037





Acute treatment of anaphylaxis in children



Traitement d’urgence de l’anaphylaxie chez les enfants



Ran D. Goldman, MD FRCPC







Abstract



Question A 3-year-old was rushed to my office after eating a friend’s chocolate bar that contained nuts. He immediately developed urticaria on his face and swelling of his lips, and he had a persistent cough. What is the best treatment for a child with anaphylaxis? Should this family receive a prescription for an epinephrine autoinjector device?

Answer Intramuscular epinephrine injection is a safe and effective treatment of anaphylaxis in children. Children with systemic allergic reactions should carry epinephrine autoinjectors at all times, and should certainly have one with them at school. In order for epinephrine autoinjectors to be effective, children and their families need to be educated on how to properly use the devices, as well as keep in mind the product’s expiration date.





Formats:









Tuesday, September 10, 2013

0 Exercise-Induced Anaphylaxis


Logo of casrepmed







Case Rep Med. 2013; 2013: 610726.

Published online 2013 March 27. doi:  10.1155/2013/610726




PMCID: PMC3622308





Exercise-Induced Anaphylaxis: A Case Report and Review of the Diagnosis and Treatment of a Rare but Potentially Life-Threatening Syndrome



Nathan T. Jaqua, 1 ,* Matthew R. Peterson, 1 and Karla L. Davis 2






Abstract



A 24-year-old male Marine with an uncomplicated medical history and a long history of strenuous, daily exercise presented to the emergency department after experiencing anaphylactic shock while running. Symptoms resolved following administration of intramuscular diphenhydramine, ranitidine, intravenous methylprednisolone, and intravenous fluids. On followup in the allergy clinic, a meticulous clinical history was obtained which elucidated a picture consistent with exercise-induced anaphylaxis. He had experienced diffuse pruritus and urticaria while exercising on multiple occasions over the last three years. His symptoms would usually increase as exercise continued. Prior to the first episode, he regularly exercised without symptoms. Exercise-induced anaphylaxis is a rare but potentially life-threatening syndrome that requires a careful clinical history and is a diagnosis of exclusion. Treatment is primarily exercise avoidance. Prophylactic mediations are inconsistently effective but are empirically used. Successful treatment with omalizumab was recently reported in a case of refractory exercise-induced anaphylaxis.





Articles from Case Reports in Medicine are provided here courtesy of Hindawi Publishing Corporation





Formats: